We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Infectious Diseases

Infectious Diseases

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Clinical Metagenomics in Sepsis: Insights from the DigiSep Randomized Controlled Trial
Critical Careclinical outcomeshealth-related quality of life

Clinical Metagenomics in Sepsis: Insights from the DigiSep Randomized Controlled Trial

By MedXY|Jul 2, 2026

The DigiSep trial assessed the impact of metagenomic next-generation sequencing (mNGS) on sepsis outcomes. While primary endpoint improvement was not significant, secondary analyses revealed benefits in mechanical ventilation duration, shoc

Evaluating the Safety of Same-Day COVID-19 and Influenza Vaccination: Insights from a Large Veterans Affairs Target Trial Emulation
Infectious DiseasesCOVID-19 vaccineinfluenza vaccine

Evaluating the Safety of Same-Day COVID-19 and Influenza Vaccination: Insights from a Large Veterans Affairs Target Trial Emulation

By MedXY|Jul 2, 2026

A large U.S. Veterans Affairs study found no increased 90-day risk of adverse events after same-day COVID-19 and influenza vaccination compared to influenza vaccination alone, supporting the safety of coadministration with updated COVID-19

Therapeutic Implications of MARS Therapy-Induced Piperacillin Clearance in Critical Liver Failure Patients
Critical CareAcute liver failureMARS therapy

Therapeutic Implications of MARS Therapy-Induced Piperacillin Clearance in Critical Liver Failure Patients

By MedXY|Jun 30, 2026

MARS therapy significantly reduces total plasma piperacillin levels by approximately one-third per session in critically ill liver failure patients, underscoring the need for therapeutic drug monitoring and individualized antibiotic dosing.

Long-Term Assessment of Rose Bengal Photodynamic Therapy in Infectious Keratitis: Insights from the REAGIR Randomized Trial
Infectious Diseasesclinical trialInfectious Keratitis

Long-Term Assessment of Rose Bengal Photodynamic Therapy in Infectious Keratitis: Insights from the REAGIR Randomized Trial

By MedXY|Jun 29, 2026

A 12-month follow-up of the REAGIR trial found no significant benefit of adjunctive rose bengal photodynamic therapy with green light over sham treatment in improving visual acuity, scar size, or complication rates in infectious keratitis.

Functional Anti-preS1 Antibody Responses and Their Role in Viral Control in Chronic Hepatitis B
Clinical Updateschronic hepatitis BHBV therapy

Functional Anti-preS1 Antibody Responses and Their Role in Viral Control in Chronic Hepatitis B

By MedXY|Jun 29, 2026

This review synthesizes evidence on preS1 antigen and anti-preS1 IgG dynamics in chronic hepatitis B, highlighting their correlations with viral replication, liver inflammation, and functional cure, and elucidates the neutralising potential

Evaluating the Safety of Prenatal RSVpreF Vaccination: Implications for Obstetric and Neonatal Outcomes
Infectious DiseasesRSV vaccinePregnancy

Evaluating the Safety of Prenatal RSVpreF Vaccination: Implications for Obstetric and Neonatal Outcomes

By MedXY|Aug 18, 2026

A large-scale VSD study found that prenatal vaccination with bivalent prefusion F RSV vaccine is generally safe, showing no increased risk for preterm birth, stillbirth, or small-for-gestational-age births but a slight increase in hypertens

Hantavirus in Pregnancy: Why Obstetricians Need a High Index of Suspicion
Infectious DiseasesPregnancyhantavirus

Hantavirus in Pregnancy: Why Obstetricians Need a High Index of Suspicion

By MedXY|Aug 18, 2026

Hantavirus infection in pregnancy is rare but potentially fatal. Obstetricians should suspect it after rodent or travel exposure, recognize rapid respiratory decline, and prioritize supportive critical care because no proven antiviral thera

Early, Broad Oseltamivir Prophylaxis May Cut Hospitalizations in Nursing Home Influenza Outbreaks
Infectious Diseasesinfluenzanursing homes

Early, Broad Oseltamivir Prophylaxis May Cut Hospitalizations in Nursing Home Influenza Outbreaks

By MedXY|Jun 15, 2026

Prompt oseltamivir prophylaxis covering at least 70% of eligible nursing home residents within 2 days of outbreak detection was associated with fewer hospitalizations, but not lower mortality.

Fast, Broad Oseltamivir Use in Nursing Home Flu Outbreaks May Cut Hospitalizations
Infectious Diseaseschemoprophylaxisinfluenza

Fast, Broad Oseltamivir Use in Nursing Home Flu Outbreaks May Cut Hospitalizations

By MedXY|Jun 15, 2026

In a real-world target trial emulation, starting oseltamivir prophylaxis within 2 days for at least 70% of eligible nursing home residents was linked to fewer hospitalizations, but not lower short-term mortality.

Post-infection Gut-Brain Disorders Affect About 1 in 10 People With DGBI Worldwide, With Distinct Psychological and Regional Patterns
Gastroenterologygastroenteritisglobal epidemiology

Post-infection Gut-Brain Disorders Affect About 1 in 10 People With DGBI Worldwide, With Distinct Psychological and Regional Patterns

By MedXY|Jun 10, 2026

A large 26-country survey found that post-infection disorders of gut-brain interaction account for 10.5% of DGBI cases and are linked to younger age, male sex, urban living, anxiety, and greater somatic symptom burden.

Culture-Negative Infective Endocarditis in the Modern Diagnostic Era: Patient Characteristics and Heterogeneity in a Nationwide Cohort
CardiologyCardiologyculture-negative infection

Culture-Negative Infective Endocarditis in the Modern Diagnostic Era: Patient Characteristics and Heterogeneity in a Nationwide Cohort

By MedXY|Jun 10, 2026

A nationwide Danish study found that culture-negative infective endocarditis was less common than previously reported, often presented without fever or sepsis, and showed higher embolic risk. PET-CT was especially useful in prosthetic valve

When a Stomach Bug Doesn’t End: The Hidden Global Burden of Post-Infection Gut Disorders
Gastroenterologychronic digestive symptomsgastroenteritis

When a Stomach Bug Doesn’t End: The Hidden Global Burden of Post-Infection Gut Disorders

By MedXY|Jun 10, 2026

A major global study shows that some people develop lasting gut-brain disorders after acute gastroenteritis, linking infections to chronic digestive and psychological symptoms.

HBsAg Seroclearance Lowers Hepatocellular Carcinoma Risk Beyond Viral Suppression in Cirrhosis, but Does Not Reduce Hepatic Decompensation
Gastroenterologychronic hepatitis Bcirrhosis

HBsAg Seroclearance Lowers Hepatocellular Carcinoma Risk Beyond Viral Suppression in Cirrhosis, but Does Not Reduce Hepatic Decompensation

By MedXY|Jun 10, 2026

In NA-treated cirrhotic chronic hepatitis B with complete viral suppression, HBsAg seroclearance was linked to lower HCC risk but not lower hepatic decompensation, reinforcing functional cure as a meaningful but incomplete clinical endpoint

Swedish Population Data Suggest SARS-CoV-2 Infection and COVID-19 Vaccination Do Not Confer a Sustained Causal Risk of New-Onset Type 1 Diabetes
Diabetes & EndocrinologyCOVID-19 vaccinationPopulation Study

Swedish Population Data Suggest SARS-CoV-2 Infection and COVID-19 Vaccination Do Not Confer a Sustained Causal Risk of New-Onset Type 1 Diabetes

By MedXY|Jun 7, 2026

In a nationwide Swedish cohort, type 1 diabetes diagnoses rose briefly after SARS-CoV-2 infection and first vaccine dose, but the signal was short-lived, supporting diagnostic acceleration rather than a durable causal effect.

Impact of Appropriate Antimicrobial Therapy on ICU Patient Outcomes: Subanalysis of the DIANA Study Dataset
Critical Careantimicrobial therapycritical care

Impact of Appropriate Antimicrobial Therapy on ICU Patient Outcomes: Subanalysis of the DIANA Study Dataset

By MedXY|Jun 5, 2026

In critically ill ICU patients with confirmed bacterial infections, appropriate empiric antimicrobial therapy was common and independently linked to lower 28-day mortality and more antimicrobial-free days.

Digital Shared Decision Support Increased STI Testing for Adolescents and Young Adults in the Emergency Department
Emergency Medicineadolescent healthemergency department

Digital Shared Decision Support Increased STI Testing for Adolescents and Young Adults in the Emergency Department

By MedXY|May 30, 2026

In a randomized controlled trial, the STIckER smartphone-based decision aid increased gonorrhea/chlamydia and pharyngeal STI testing in emergency department patients aged 14 to 24 years, while improving decisional clarity, satisfaction, and

Large-Scale Meta-Analysis Finds Higher Influenza and Shingles Risk with JAK-STAT Inhibitors
Dermatologyatopic dermatitisInfection Risk

Large-Scale Meta-Analysis Finds Higher Influenza and Shingles Risk with JAK-STAT Inhibitors

By MedXY|May 27, 2026

A large meta-analysis found JAK-STAT inhibitors slightly increased influenza, bronchitis, and herpes zoster risk, especially in atopic dermatitis, while serious and opportunistic infections were not significantly increased.

Rapid Respiratory Point-of-Care Testing and Antibiotic Use in Primary Care: A Randomized Clinical Trial
Family Medicine & Nutritionantibiotic stewardshipPoint-of-Care Testing

Rapid Respiratory Point-of-Care Testing and Antibiotic Use in Primary Care: A Randomized Clinical Trial

By MedXY|May 26, 2026

A randomized trial found that rapid respiratory point-of-care testing did not reduce same-day antibiotic prescribing in primary care, though it was safe and may help when a virus is detected.

Diabetes, Male Sex, and Low HBsAg, HDV RNA, and ALT Predict Spontaneous HDV Suppression in Chronic Hepatitis D
GastroenterologyALTchronic hepatitis D

Diabetes, Male Sex, and Low HBsAg, HDV RNA, and ALT Predict Spontaneous HDV Suppression in Chronic Hepatitis D

By MedXY|May 20, 2026

In 1,610 untreated chronic hepatitis D patients, spontaneous HDV suppression was uncommon but increased over time. Diabetes, male sex, and lower baseline HBsAg, HDV RNA, and ALT predicted suppression and fewer liver-related events.

Lower Airway Dysbiosis in NTM-Positive Bronchiectasis Is Linked to NET-Dominant Severe Phenotypes
Infectious Diseasesairway microbiomebronchiectasis

Lower Airway Dysbiosis in NTM-Positive Bronchiectasis Is Linked to NET-Dominant Severe Phenotypes

By MedXY|May 18, 2026

In NTM-positive bronchiectasis, lower airway dysbiosis involving Mycobacterium and oral bacteria is linked to higher NET levels and more severe disease phenotypes, suggesting that the broader airway microbiome may shape inflammation and out

Prev
3 / 16
12345…16
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles